In the preceding three months, 12 analysts have released ratings for 10x Genomics (NASDAQ:TXG), presenting a wide array of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 1 | 5 | 0 | 2 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 1 | 1 | 0 | 1 |
| 2M Ago | 0 | 0 | 1 | 0 | 0 |
| 3M Ago | 3 | 0 | 3 | 0 | 1 |
Analysts have set 12-month price targets for 10x Genomics, revealing an average target of $33.0, a high estimate of $55.00, and a low estimate of $16.00. Observing a downward trend, the current average is 33.02% lower than the prior average price target of $49.27.
Analyzing Analyst Ratings: A Detailed Breakdown
In examining recent analyst actions, we gain insights...
Login or create a forever free account to read this news
Sign up/Log in